Alliance Nctn Foundation

Alliance Nctn Foundation, a Chicago-based tax-exempt non-profit research foundation, serves as a prime recipient on federal grants and contracts for clinical trial data collection, standardization, integration, and analysis work supporting regulatory science and biomedical research initiatives at civilian health agencies.

The foundation operates almost exclusively as a prime recipient across its recent federal footprint — five of six awards are prime, with only one sub-award (a subaward from Brigham and Women's Hospital under an NIH National Cancer Institute grant to support operational transition). Customer concentration sits with health agencies. The Food and Drug Administration accounts for three awards ($1.9 million combined potential value) across real-world radiographic data collection and adverse-event reporting work tied to the ICAREDATA research institute initiative; the National Institutes of Health National Cancer Institute holds two awards for clinical trial data management; and the Defense Health Agency anchors a $4.58 million Project Grant (CFDA 12.420) under the Military Medical Research and Development program effective July 1, 2026, through June 30, 2030, for long-term follow-up and data collection services on the COMET (Comparison of an Operation to Monitoring, with Option of Endocrine Therapy) clinical study. Work is performed in Chicago, Illinois, with performance spanning military and civilian biomedical research portfolios.

Representative work includes a $138,204.70 FDA definitive contract awarded September 2022 for real-world collection of radiographic images and treatment-emergent adverse event data to support ICAREDATA next-phase development (ultimate completion December 31, 2024), prior FDA awards in 2020 and 2022 for ICAREDATA data capture and standardization, and the four-year Defense Health Agency Project Grant beginning July 2026 for the COMET study long-term follow-up. Service Contract Inventory captures $2.2 million in SCI-reportable federal services invoiced between FY2023 and FY2024 (zero invoicing in FY2022), with the vendor delivering services as sole prime (zero subcontractor hours recorded across SCI records). The foundation demonstrates no FTE staffing in SCI-reported records — a reporting artifact indicating that either clinical or research staff are not captured in SCI time-and-labor systems, or the work is structured as pass-through grants rather than labor-hour billing. One award (an FDA contract) reaches completion within the next twenty-four months and faces recompete exposure. Alliance Nctn Foundation competes without set-aside designations in full-and-open federal health research procurement, with no GWAC or IDV parent vehicles in its recent footprint.